These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 26338174)

  • 1. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
    Pan Y; Khalil H; Nicolazzo JA
    Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease.
    Ajith TA
    Curr Clin Pharmacol; 2018; 13(4):252-260. PubMed ID: 30084334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood-brain barrier and brain docosahexaenoic acid levels.
    Pan Y; Morris ER; Scanlon MJ; Marriott PJ; Porter CJH; Nicolazzo JA
    J Neurochem; 2018 Jul; 146(2):186-197. PubMed ID: 29582413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
    Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
    J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
    Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
    Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
    Pan Y; Choy KHC; Marriott PJ; Chai SY; Scanlon MJ; Porter CJH; Short JL; Nicolazzo JA
    J Neurochem; 2018 Jan; 144(1):81-92. PubMed ID: 29105065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
    Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid.
    Pan Y; Scanlon MJ; Owada Y; Yamamoto Y; Porter CJ; Nicolazzo JA
    Mol Pharm; 2015 Dec; 12(12):4375-85. PubMed ID: 26455443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.
    Patrick RP
    FASEB J; 2019 Feb; 33(2):1554-1564. PubMed ID: 30289748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.
    Lim GP; Calon F; Morihara T; Yang F; Teter B; Ubeda O; Salem N; Frautschy SA; Cole GM
    J Neurosci; 2005 Mar; 25(12):3032-40. PubMed ID: 15788759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
    Ma QL; Teter B; Ubeda OJ; Morihara T; Dhoot D; Nyby MD; Tuck ML; Frautschy SA; Cole GM
    J Neurosci; 2007 Dec; 27(52):14299-307. PubMed ID: 18160637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
    Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
    J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases.
    Lo Van A; Sakayori N; Hachem M; Belkouch M; Picq M; Lagarde M; Osumi N; Bernoud-Hubac N
    Biochimie; 2016 Nov; 130():163-167. PubMed ID: 27496085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
    Cole GM; Frautschy SA
    Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta
    Ochiai Y; Uchida Y; Tachikawa M; Couraud PO; Terasaki T
    J Neurochem; 2019 Aug; 150(4):385-401. PubMed ID: 31091338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.
    Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
    Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
    J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.